Etiology of Atherosclerosis Flashcards
3 stages
fatty streak formation, plaque formation, plaque disruption
fatty streak formation
fatty yellow discolorations on the arterial inner surface that neither protrude into the lumen nor disrupt blood flow
plaque formation
arterial fatty streaks increase in size due to the inflammatory response as the lipid deposits accumulate
plaque disruption
as plaques grow in size their lipid cores become large which causes foam cell death, which leads to plaque necrosis, instability and increased potential for thrombogenesis.
modifiable risk factors for hyperlipidemia
obesity, hypertension, diabetes, smoking, and physical inactivity
biomarkers
C-reactive protein, hyperhomocysteinemia, and lipoprotein(a)
Risk enhancing factors
Family hx of premature ASCVD; primary hypercholesterolemia; metabolic syndrome; chronic kidney disease; chronic inflammatory conditions; history of POI, high risk race/ethnicity; persistently elevated primary hypertriglyceridemia and/or other biomarkers associated with increased risk
elevated hcCRP
2.0 and above
elevated Lp(a)
50mg/dL and above or 125 nmol/L and above (order for fam hx premature ASCVD)
elevated Apo B
130 mg/dL (order if triglyceride is 200 or more)
Stratification of hsCRP for ASCVD risk
Low risk: < 1 mg/L
Moderate risk: 1–3 mg/L
High risk: > 3 mg/L
An hsCRP level >10 mg/L has been observed in acute plaque rupture, which may lead
to thrombosis
Homocysteine levels
High homocysteine blood levels (greater than 15
mcmol/L) are associated with increased oxidative
stress and secretion of proinflammatory factors.
Both mechanisms stimulate smooth cell proliferation and accelerate atherosclerosis.
Importance of lipoprotein(a)
a subtype of LDL that
includes apoprotein A (Apo A) in its structure.
Role of lipoprotein(a) in atherosclerosis
(1) inhibition
of fibrinolysis (2) enhanced capacity to traverse the arterial endothelium (3) low affinity
for the LDL-receptor mediated clearance from circulation
Using lipoprotein(a) in treatment decisions
If > than 30 mg/dL in patients with an elevated total cholesterol:HDL ratio (> 5.5) or other major RFs risk indicates the need for a more aggressive therapy to further lower LDL
Lipids
play a crucial role in living organisms as a source of energy and as structural constituents of cell membranes and complex molecules such
as steroids and eicosanoids (e.g., prostaglandins,
thromboxane A2, leukotrienes) and lipid-soluble
vitamins
Phospholipids
are structural components of cell membranes, myelin, lipoproteins, and blood clotting factors.
Cholesterol
Cholesterol is a structural component of cell membranes and a precursor of other steroids, namely steroid hormones, bile acids, and signaling molecules. It is mainly synthesized in the liver but is also absorbed in the intestine from dietary sources and enterohepatic circulation
Fatty acids
are a source of energy and > 100 fatty acids have been identified. Unsaturated fatty acids (monounsaturated or
polyunsaturated) vs Saturated fatty acids. The former are
waxy solids at room temperature, while unsaturated
fatty acids are liquids.
Triglycerides
The main source of dietary fat and can also be synthesized in the liver from intermediary metabolites of excess carbohydrates. (2) They accumulate in adipose tissue and muscle cells and can later
be mobilized as free fatty acids as a source of energy when dietary sources are not
readily available
Transfatty acids
Some edible fats, including hydrogenated vegetable products (oils, margarines, and
shortenings) are rich in trans fatty acids which are solid at room temperature
Dangers of transfat
They are inexpensive to produce, give foods a desirable texture and taste, have a long shelf-life, and can be reused
to deep-fry foods. However, their increased dietary intake is associated with increased ASCVD.
Lipoproteins
responsible for transporting cholesterol and triglycerides in the plasma
Apoproteins
Apoproteins are a famly of surface proteins that have various metabolic functions (Apo A, APo B, Apo C, and Apo E)
Chylomicrons
are large lipoproteins that carry mostly triglycerides and cholesterol. can only be reduced by reducing dietary fat consumption
VLDL
are smaller than chylomicrons but carry a significant portion of triglycerides and cholesterol
IDL
are created when VDLD is depleted
LDL
the most cholesterol rich lipoprotein; can be increased due to genetic mutations of either the LDL receptor or Apo B-100, thyroid or estrogen deficiencies; lowering LDL is the primary goal of treatment and prevention of ASCVD
HDL
the smallest but densest lipoproteins (protein content of 33%); removes cholesterol from the periphery and transports it to the liver, and is excreted in bile; moderate to high levels may help prevent ASCVD